Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Interventional
Phase 2
The Second Affiliated Hospital of Guangzhou Medical University
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Last Updated: August 21, 2024 Notice- Information is sourced from public registries and may not reflect real-time changes at the local site.
To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.
Description: Intra-tumor injection of above drugs for patients with previous treatment with PDL1 antibody and relapsed.
Interventions:
Injection of drug-eluting microspheres with multiple drugs into solid tumors
Outcome Measures
Primary Outcome Measures
Assessing safety and treatment efficacy on intra-tumor injection of DEB for advanced tumorsup to 36 months
Assessing incidence of side effects and primary clinical response of the intra-tumor injection of DEB in advanced solid cancers, including CR, PR, SD, and PD.
Secondary Outcome Measures
None
Bookmark trial
Share Trial
Download Trial
Do you think this trial is incorrectly appearing?
Report Trial
Download Trial
Trial Sites
This study has 1 trial site
The Second Affiliated Hospital of Guangzhou Medical University